<

 
Data updated 2025-04-25 00:05:00
Translation DK > English
Need help for the searches?
[DISPLAY PATENT]
 
Choose application no.
 
Application no. and date04786150.5 (espacenet)  (Federated)  (European Patent Register), 20040730
Patent/reg. no. and dateDK/EP 1656372, 20130410
Publication date20060517
Priority no. and dateUS 491641 P, 20030730, US 531598 P, 20031219, US 572246 P, 20040518
EP pub. no. and date EP 1656372 20060517
Effective date
Applicant/ownerRigel Pharmaceuticals, Inc., 1180 Veterans Boulevard
South San Francisco, CA 94080, US
Applicant ref. no.RIGEL P.0084.13.EP
InventorCLOUGH, Jeffrey, 3520 Bay Road
Redwood City, CA 94063, US,
KEIM, Holger, 25 Buckthorn Way
Menlo Park, CA 94025, US,
SYLVAIN, Catherine, 24 Prague Street
San Mateo, CA 94401, US,
ANKUSH, Argade, 639-1 Catamaran Street
Foster City, CA 94404, US,
CARROLL, David, 87 Dolores Street, Apt. 105
San Francisco, CA 94103, US,
BHAMIDIPATI, Somasekhar, 888 Foster City Boulevard, No. Q2
Foster City, CA 94404, US,
RAJINDER, Singh, 1832 Hillman Avenue
Belmont, CA 92002, US,
LI, Hui, 2576 Amethyst Drive
Santa Clara, CA 95051, US
RepresentativeRWS Group, RWS Compass House Vanwall Business Park, Vanwall Road Maidenhead, Berkshire SL6 4UB , GB
Opponent
IPC ClassC07D 413/14 (2006.01) 
Title2,4-PYRIMIDINDIAMINFORBINDELSER TIL ANVENDELSE TIL BEHANDLING ELLER FOREBYGGELSE AF AUTOIMMUNSYGDOMME
Int. application no.US2004024716
Int. publication no.WO2005016893
Related patent (certificate)
StatusUdløbet
Pædiatrisk forlængelse-
Udløbsdato for pædiatrisk forlængelse-

 
Home | Danish Patent and Trademark Office, Helgeshøj Allé 81, 2630 Tåstrup, Denmark Tel.: +45 4350 8000, email | Contact